annual FCF:
-$354.66M+$53.41M(+13.09%)Summary
- As of today (August 20, 2025), NTLA annual free cash flow is -$354.66 million, with the most recent change of +$53.41 million (+13.09%) on December 31, 2024.
- During the last 3 years, NTLA annual FCF has fallen by -$116.87 million (-49.15%).
- NTLA annual FCF is now -1284.40% below its all-time high of $29.94 million, reached on December 31, 2016.
Performance
NTLA Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$99.86M+$49.80M(+33.28%)Summary
- As of today (August 20, 2025), NTLA quarterly free cash flow is -$99.86 million, with the most recent change of +$49.80 million (+33.28%) on June 30, 2025.
- Over the past year, NTLA quarterly FCF has dropped by -$40.66 million (-68.69%).
- NTLA quarterly FCF is now -250.39% below its all-time high of $66.40 million, reached on June 30, 2016.
Performance
NTLA quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$421.82M-$40.66M(-10.67%)Summary
- As of today (August 20, 2025), NTLA TTM free cash flow is -$421.82 million, with the most recent change of -$40.66 million (-10.67%) on June 30, 2025.
- Over the past year, NTLA TTM FCF has dropped by -$39.16 million (-10.24%).
- NTLA TTM FCF is now -1021.70% below its all-time high of $45.77 million, reached on June 30, 2016.
Performance
NTLA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
NTLA Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.1% | -68.7% | -10.2% |
| 3 y3 years | -49.1% | -12.1% | -23.3% |
| 5 y5 years | -222.3% | -277.1% | -917.9% |
NTLA Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -49.1% | +13.1% | -68.7% | +33.3% | -23.3% | at low |
| 5 y | 5-year | -563.0% | +13.1% | -277.1% | +33.3% | -917.9% | at low |
| alltime | all time | -1284.4% | +13.1% | -250.4% | +33.3% | -1021.7% | at low |
NTLA Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$99.86M(-33.3%) | -$421.82M(+10.7%) |
| Mar 2025 | - | -$149.66M(+73.7%) | -$381.15M(+7.5%) |
| Dec 2024 | -$354.66M(-13.1%) | -$86.18M(+0.1%) | -$354.66M(-2.3%) |
| Sep 2024 | - | -$86.12M(+45.5%) | -$363.06M(-5.1%) |
| Jun 2024 | - | -$59.20M(-51.9%) | -$382.65M(-8.5%) |
| Mar 2024 | - | -$123.17M(+30.2%) | -$418.08M(+2.5%) |
| Dec 2023 | -$408.07M(+17.7%) | -$94.57M(-10.5%) | -$408.07M(+0.2%) |
| Sep 2023 | - | -$105.71M(+11.7%) | -$407.28M(+6.0%) |
| Jun 2023 | - | -$94.62M(-16.4%) | -$384.33M(+1.5%) |
| Mar 2023 | - | -$113.16M(+20.7%) | -$378.77M(-3.3%) |
| Dec 2022 | -$346.85M(+45.9%) | -$93.78M(+13.3%) | -$391.68M(+10.2%) |
| Sep 2022 | - | -$82.76M(-7.1%) | -$355.42M(+3.9%) |
| Jun 2022 | - | -$89.07M(-29.3%) | -$342.21M(+10.7%) |
| Mar 2022 | - | -$126.06M(+119.2%) | -$309.06M(+30.0%) |
| Dec 2021 | -$237.79M(+344.5%) | -$57.52M(-17.3%) | -$237.79M(+7.4%) |
| Sep 2021 | - | -$69.56M(+24.4%) | -$221.50M(+22.2%) |
| Jun 2021 | - | -$55.92M(+2.1%) | -$181.19M(+163.0%) |
| Mar 2021 | - | -$54.79M(+32.9%) | -$68.89M(+28.8%) |
| Dec 2020 | -$53.50M | -$41.23M(+40.9%) | -$53.50M(+23.0%) |
| Sep 2020 | - | -$29.26M(-151.9%) | -$43.50M(+5.0%) |
| Jun 2020 | - | $56.38M(-243.1%) | -$41.44M(-67.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$39.39M(+26.1%) | -$126.44M(+14.9%) |
| Dec 2019 | -$110.03M(+62.7%) | -$31.23M(+14.8%) | -$110.03M(+23.7%) |
| Sep 2019 | - | -$27.20M(-5.0%) | -$88.93M(+16.7%) |
| Jun 2019 | - | -$28.62M(+24.5%) | -$76.20M(+7.4%) |
| Mar 2019 | - | -$22.99M(+126.9%) | -$70.98M(+5.0%) |
| Dec 2018 | -$67.61M(-10.3%) | -$10.13M(-30.0%) | -$67.61M(-16.7%) |
| Sep 2018 | - | -$14.47M(-38.1%) | -$81.19M(-5.5%) |
| Jun 2018 | - | -$23.39M(+19.2%) | -$85.87M(+8.1%) |
| Mar 2018 | - | -$19.62M(-17.2%) | -$79.43M(+5.4%) |
| Dec 2017 | -$75.37M(-351.7%) | -$23.70M(+23.7%) | -$75.37M(+8.5%) |
| Sep 2017 | - | -$19.15M(+13.0%) | -$69.48M(+18.7%) |
| Jun 2017 | - | -$16.95M(+8.9%) | -$58.54M(-335.9%) |
| Mar 2017 | - | -$15.56M(-12.7%) | $24.81M(-17.1%) |
| Dec 2016 | $29.94M(-793.6%) | -$17.82M(+116.9%) | $29.94M(-27.7%) |
| Sep 2016 | - | -$8.21M(-112.4%) | $41.42M(-9.5%) |
| Jun 2016 | - | $66.40M(-736.7%) | $45.77M(-340.2%) |
| Mar 2016 | - | -$10.43M(+64.5%) | -$19.05M(+341.3%) |
| Dec 2015 | -$4.32M(+66.2%) | -$6.34M(+63.9%) | -$4.32M(-313.4%) |
| Sep 2015 | - | -$3.87M(-343.9%) | $2.02M(-65.7%) |
| Jun 2015 | - | $1.59M(-63.2%) | $5.89M(+36.8%) |
| Mar 2015 | - | $4.31M | $4.31M |
| Dec 2014 | -$2.60M | - | - |
FAQ
- What is Intellia Therapeutics, Inc. annual free cash flow?
- What is the all time high annual FCF for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual FCF year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly FCF year-on-year change?
- What is Intellia Therapeutics, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. TTM FCF year-on-year change?
What is Intellia Therapeutics, Inc. annual free cash flow?
The current annual FCF of NTLA is -$354.66M
What is the all time high annual FCF for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual free cash flow is $29.94M
What is Intellia Therapeutics, Inc. annual FCF year-on-year change?
Over the past year, NTLA annual free cash flow has changed by +$53.41M (+13.09%)
What is Intellia Therapeutics, Inc. quarterly free cash flow?
The current quarterly FCF of NTLA is -$99.86M
What is the all time high quarterly FCF for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly free cash flow is $66.40M
What is Intellia Therapeutics, Inc. quarterly FCF year-on-year change?
Over the past year, NTLA quarterly free cash flow has changed by -$40.66M (-68.69%)
What is Intellia Therapeutics, Inc. TTM free cash flow?
The current TTM FCF of NTLA is -$421.82M
What is the all time high TTM FCF for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high TTM free cash flow is $45.77M
What is Intellia Therapeutics, Inc. TTM FCF year-on-year change?
Over the past year, NTLA TTM free cash flow has changed by -$39.16M (-10.24%)